Burns
Volume 36, Issue 5 , Pages 599-605 , August 2010

Glucose metabolism in burn patients: The role of insulin and other endocrine hormones

  • Nikiforos Ballian

      Affiliations

    • Department of Surgery, University of Wisconsin, Madison, WI, United States
    • ,
  • Atoosa Rabiee

      Affiliations

    • Department of Surgery, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD, United States
    • Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD, United States
    • ,
  • Dana K. Andersen

      Affiliations

    • Department of Surgery, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD, United States
    • ,
  • Dariush Elahi

      Affiliations

    • Department of Surgery, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD, United States
    • Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD, United States
    • Corresponding Author InformationCorresponding author at: Department of Surgery, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, A5, Baltimore, MD 21224, United States. Tel.: +1 410 550 2385; fax: +1 410 550 1895.
    • ,
  • B. Robert Gibson

      Affiliations

    • Department of Surgery, Johns Hopkins University School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD, United States

,Accepted 11 November 2009.

References 

  1. Ipaktchi K, Arbabi S. Advances in burn critical care. Crit Care Med. 2006;34(9 Suppl.):S239–S244
  2. Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ, Jeschke MG. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab. 2009;94(5):1656–1664
  3. Gore DC, Jahoor F. Glutamine kinetics in burn patients. Comparison with hormonally induced stress in volunteers. Arch Surg. 1994;129(12):1318–1323
  4. Gore DC, Chinkes DL, Wolf SE, Sanford AP, Herndon DN, Wolfe RR. Quantification of protein metabolism in vivo for skin, wound, and muscle in severe burn patients. JPEN. 2006;30(4):331–338
  5. Gore DC, Wolf SE, Herndon DN, Wolfe RR. Relative influence of glucose and insulin on peripheral amino acid metabolism in severely burned patients. JPEN. 2002;26(5):271–277
  6. Ferrando AA, Chinkes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg. 1999;229(1):11–18
  7. Sakurai Y, Aarsland A, Herndon DN, Chinkes DL, Pierre E, Nguyen TT, et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg. 1995;222(3):283-94; 94-7
  8. Jahoor F, Herndon DN, Wolfe RR. Role of insulin and glucagon in the response of glucose and alanine kinetics in burn-injured patients. J Clin Invest. 1986;78(3):807–814
  9. Gore DC, Chinkes DL, Hart DW, Wolf SE, Herndon DN, Sanford AP. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med. 2002;30(11):2438–2442
  10. Vanhorebeek I, Ellger B, De Vos R, Boussemaere M, Debaveye Y, Perre SV, et al. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Crit Care Med. 2009;37(4):1355–1364
  11. Wolfe RR, Jahoor F, Herndon DN, Miyoshi H. Isotopic evaluation of the metabolism of pyruvate and related substrates in normal adult volunteers and severely burned children: effect of dichloroacetate and glucose infusion. Surgery. 1991;110(1):54–67
  12. Yu YM, Tompkins RG, Ryan CM, Young VR. The metabolic basis of the increase of the increase in energy expenditure in severely burned patients. JPEN. 1999;23(3):160–168
  13. Yarmush DM, MacDonald AD, Foy BD, Berthiaume F, Tompkins RG, Yarmush ML. Cutaneous burn injury alters relative tricarboxylic acid cycle fluxes in rat liver. J Burn Care Rehabil. 1999;20(4):292–302
  14. Burke JF, Wolfe RR, Mullany CJ, Mathews DE, Bier DM. Glucose requirements following burn injury. Parameters of optimal glucose infusion and possible hepatic and respiratory abnormalities following excessive glucose intake. Ann Surg. 1979;190(3):274–285
  15. Wolfe RR, Durkot MJ, Allsop JR, Burke JF. Glucose metabolism in severely burned patients. Metabolism. 1979;28(10):1031–1039
  16. Wolfe RR. Metabolic response to burn injury: nutritional implications. Keio J Med. 1993;42(1):1–8
  17. Jahoor F, Shangraw RE, Miyoshi H, Wallfish H, Herndon DN, Wolfe RR. Role of insulin and glucose oxidation in mediating the protein catabolism of burns and sepsis. Am J Physiol. 1989;257(3 Pt 1):E323–E331
  18. Yamaguchi Y, Yu YM, Zupke C, Yarmush DM, Berthiaume F, Tompkins RG, et al. Effect of burn injury on glucose and nitrogen metabolism in the liver: preliminary studies in a perfused liver system. Surgery. 1997;121(3):295–303
  19. Durkot MJ, Wolfe RR. Effects of adrenergic blockade on glucose kinetics in septic and burned guinea pigs. Am J Physiol. 1981;241(3):R222–R227
  20. Wolfe RR, Herndon DN, Jahoor F, Miyoshi H, Wolfe M. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med. 1987;317(7):403–408
  21. Lee K, Berthiaume F, Stephanopoulos GN, Yarmush DM, Yarmush ML. Metabolic flux analysis of postburn hepatic hypermetabolism. Metab Eng. 2000;2(4):312–327
  22. Cree MG, Wolfe RR. Postburn trauma insulin resistance and fat metabolism. Am J Physiol Endocrinol Metab. 2008;294(1):E1–E9
  23. Gauglitz GG, Herndon DN, Jeschke MG. Insulin resistance postburn: underlying mechanisms and current therapeutic strategies. J Burn Care Res. 2008;29(5):683–694
  24. Carter EA, Tompkins RG, Babich JW, Correia J, Bailey EM, Fischman AJ. Thermal injury in rats alters glucose utilization by skin, wound, and small intestine, but not by skeletal muscle. Metabolism. 1996;45(9):1161–1167
  25. DeFronzo R. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia. 1981;21:165–171
  26. Fang CH, Li BG, James JH, Fischer JE, Hasselgren PO. Cytokines block the effects of insulin-like growth factor-I (IGF-I) on glucose uptake and lactate production in skeletal muscle but do not influence IGF-I-induced changes in protein turnover. Shock. 1997;8(5):362–367
  27. Pidcoke HF, Salinas J, Wanek SM, Concannon M, Loo F, Wirfel KL, et al. Patterns of exogenous insulin requirement reflect insulin sensitivity changes in trauma. Am J Surg. 2007;194(6):798–803[discussion]
  28. Sugita H, Kaneki M, Sugita M, Yasukawa T, Yasuhara S, Martyn JA. Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle. Am J Physiol Endocrinol Metab. 2005;288(3):E585–E591
  29. Gore DC, Wolf SE, Sanford AP, Herndon DN, Wolfe RR. Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. Am J Physiol Endocrinol Metab. 2004;286(4):E529–E534
  30. Zhang XJ, Chinkes DL, Irtun O, Wolfe RR. Anabolic action of insulin on skin wound protein is augmented by exogenous amino acids. Am J Physiol Endocrinol Metab. 2002;282(6):E1308–E1315
  31. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma. 2001;51(3):540–544
  32. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553–591
  33. Black CT, Hennessey PJ, Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma. 1990;30(7):830–832[discussion 2–3]
  34. von Kanel R, Mills PJ, Dimsdale JE. Short-term hyperglycemia induces lymphopenia and lymphocyte subset redistribution. Life Sci. 2001;69(3):255–262
  35. Perner A, Nielsen SE, Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intens Care Med. 2003;29(4):642–645
  36. Mowlavi A, Andrews K, Milner S, Herndon DN, Heggers JP. The effects of hyperglycemia on skin graft survival in the burn patient. Ann Plast Surg. 2000;45(6):629–632
  37. Weekers F, Giulietti AP, Michalaki M, Coopmans W, Van Herck E, Mathieu C, et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology. 2003;144(12):5329–5338
  38. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005;115(8):2277–2286
  39. Padfield KE, Astrakas LG, Zhang Q, Gopalan S, Dai G, Mindrinos MN, et al. Burn injury causes mitochondrial dysfunction in skeletal muscle. Proc Natl Acad Sci USA. 2005;102(15):5368–5373
  40. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355(9206):773–778
  41. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32(10):2426–2432
  42. Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med. 2004;5(4):329–336
  43. Gore DC, Wolf SE, Herndon DN, Wolfe RR. Metformin blunts stress-induced hyperglycemia after thermal injury. J Trauma. 2003;54(3):555–561
  44. Arora NS, Rochester DF. Respiratory muscle strength and maximal voluntary ventilation in undernourished patients. Am Rev Respir Dis. 1982;126(1):5–8
  45. Biolo G, Declan Fleming RY, Wolfe RR. Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. J Clin Invest. 1995;95(2):811–819
  46. Thomas SJ, Morimoto K, Herndon DN, Ferrando AA, Wolfe RR, Klein GL, et al. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery. 2002;132(2):341–347
  47. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359–1367
  48. Holm C, Horbrand F, Mayr M, von Donnersmarck GH, Muhlbauer W. Acute hyperglycaemia following thermal injury: friend or foe?. Resuscitation. 2004;60(1):71–77
  49. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E, et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006;55(4):1096–1105
  50. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359–366
  51. Jeschke MG, Einspanier R, Klein D, Jauch KW. Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med. 2002;8(8):443–450
  52. Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg. 2004;239(4):553–560
  53. Wu X, Thomas SJ, Herndon DN, Sanford AP, Wolf SE. Insulin decreases hepatic acute phase protein levels in severely burned children. Surgery. 2004;135(2):196–202
  54. Jeschke MG, Barrow RE, Herndon DN. Extended hypermetabolic response of the liver in severely burned pediatric patients. Arch Surg. 2004;139(6):641–647
  55. Jeschke MG, Rensing H, Klein D, Schubert T, Mautes AE, Bolder U, et al. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol. 2005;42(6):870–879
  56. Klein D, Schubert T, Horch RE, Jauch KW, Jeschke MG. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg. 2004;240(2):340–349
  57. Cochran A, Davis L, Morris SE, Saffle JR. Safety and efficacy of an intensive insulin protocol in a burn-trauma intensive care unit. J Burn Care Res. 2008;29(1):187–191
  58. Pham TN, Warren AJ, Phan HH, Molitor F, Greenhalgh DG, Palmieri TL. Impact of tight glycemic control in severely burned children. J Trauma. 2005;59(5):1148–1154
  59. Gibson BR, Galiatsatos P, Rabiee A, Eaton L, Abu-Hamdah R, Christmas C, et al. Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit as in the surgical intensive care unit. Surgery. 2009;146(5):922–930
  60. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449–461
  61. Malmberg KA, Efendic S, Ryden LE. Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMI. Diabetes Care. 1994;17(9):1007–1014
  62. Goldberg PA. Memoirs of a root canal salesman: the successful implementation of a hospital-wide intravenous insulin infusion protocol. Endocr Pract. 2006;12(Suppl. 3):79–85
  63. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10(Suppl 2):21–33
  64. Aarsland A, Chinkes D, Wolfe RR. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest. 1996;98(9):2008–2017
  65. Gibbons GF. Insulin, diabetes and hepatic very-low-density lipoprotein metabolism. Biochem Soc Trans. 1989;17(1):49–51
  66. Aarsland A, Chinkes DL, Sakurai Y, Nguyen TT, Herndon DN, Wolfe RR. Insulin therapy in burn patients does not contribute to hepatic triglyceride production. J Clin Invest. 1998;101(10):2233–2239
  67. Emanuele NV, Emanuele MA, Morgan MO, Sulo D, Yong S, Kovacs EJ, et al. Ethanol potentiates the acute Fatty infiltration of liver caused by burn injury: prevention by insulin treatment. J Burn Care Res. 2009;30(3):482–488
  68. Shangraw RE, Jahoor F, Miyoshi H, Neff WA, Stuart CA, Herndon DN, et al. Differentiation between septic and postburn insulin resistance. Metabolism. 1989;38(10):983–989
  69. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 1995;333(9):550–554
  70. Cree MG, Zwetsloot JJ, Herndon DN, Qian T, Morio B, Fram R, et al. Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate. Ann Surg. 2007;245(2):214–221
  71. Jenkins RC, Ross RJ. Growth hormone therapy for protein catabolism. QJM. 1996;89(11):813–819
  72. Tessari P, Trevisan R, Inchiostro S, Biolo G, Nosadini R, De Kreutzenberg SV, et al. Dose–response curves of effects of insulin on leucine kinetics in humans. Am J Physiol. 1986;251(3 Pt 1):E334–E342
  73. Kettelhut IC, Wing SS, Goldberg AL. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab Rev. 1988;4(8):751–772

PII: S0305-4179(09)00560-9

doi: 10.1016/j.burns.2009.11.008

Burns
Volume 36, Issue 5 , Pages 599-605 , August 2010

Article Tools

* Image Usage & Resolution